(83 days)
No
The document describes a sterile, disposable reservoir for use with infusion pumps and does not mention any AI or ML capabilities.
No.
The device is described as a sterile ambulatory reservoir intended for use as an accessory to infusion pumps, replacing another medication cassette. It does not directly perform a therapeutic function but rather holds medication for delivery by a therapeutic device (infusion pump).
No
Explanation: The S.P.A.R. Sterile Ambulatory Reservoir is described as an accessory for infusion pumps, intended to hold medication. Its function is to deliver medication, not to diagnose a condition. The performance studies mentioned relate to mechanical properties (stroke displacement) of the reservoir, not diagnostic capabilities.
No
The device description clearly states it is a "sterile, disposable, nonpyrogenic, tamper proof (evident), ambulatory, reservoir system," which are physical characteristics of a hardware component, not software. The performance studies also focus on physical properties like stroke displacement under varying conditions.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes the device as a reservoir for use with infusion pumps to deliver medication. This is a therapeutic function, not a diagnostic one.
- Device Description: The description focuses on the physical characteristics of the reservoir and its use in delivering fluids. There is no mention of analyzing biological samples or providing diagnostic information.
- Lack of IVD Indicators: The text does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological samples (blood, urine, tissue, etc.)
- Detecting or measuring substances in biological samples
- Providing information for diagnosis, monitoring, or prognosis of a disease or condition
The device is clearly intended to be an accessory for drug delivery via infusion pumps.
N/A
Intended Use / Indications for Use
The S.P.A.R.TM Ambulatory Reservoir is intended for use as an accessory to the SIMS Deltec CADD-PCA® Model 5800 and CADD-Prizm® Model 6100 infusion pumps by replacing the Deltec Medication Cassette "10 Model 2050 - 50 mL and 2100 - 100 mL with S.P.A.R.TM Sterile Ambulatory Reservoir.
The use of the S.P.A.R.T™ Ambulatory Reservoir as an accessory to the SIMS Deltec CADD-PCA® Model 5800 infusion pump was previously studied and approved for marketing by the FDA on July 18, 1997 (510(k) -K962159). The current 510(k) - 990091, covers studies and information on the SIMS Deltec CADD-Prizm® Model 6100 infusion pump.
Product codes
MRZ
Device Description
The S.P.A.R.TM Sterile Ambulatory Reservoir is a sterile, disposable, nonpyrogenic, tamper proof (evident), ambulatory, reservoir system designed for use with the SIMS Deltec CADD-PCA® Model 5800 and CADD-Prizm® Model 6100 infusion pumps.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The study carried out, therefore, identified statistically significant factors affecting stroke displacement from both the original Deltec reservoir and the S.P.A.R.TM reservoir when coupled with the Deltec CADD-Prizm® Model 6100 infusion pump. The factors investigated were temperature, back pressure in the delivery line, fluid viscosity, magnitude of flow rate, and reservoir type.
Measured stroke displacement data established the equivalence of the two reservoirs in that both are affected by the same factors in a similar manner. Reducing temperature from 40℃ to 2℃ reduces the stroke displacement in both S.P.A.R.TM and Deltec reservoirs. Changing fluid viscosity from 0.9% Sodium Chloride Injection USP to 30% Dextrose Injection, USP does not affect stroke displacement in either reservoir. Increasing back pressure from -100 mmHg to 300 mmHg reduces stroke displacement in both reservoirs. Increasing flow rate from 0.1 ml/hr to 30 mL/hr increases stroke displacement in both reservoirs. Thus, the S.P.A.R.TM reservoir can be considered substantially equivalent to the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
SIMS Deltec Medication CassetteTM (K843772
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5725 Infusion pump.
(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).
0
4-6-99
510(k) SUMMARY
| 1. | Classification Name: | Infusion Pump, Accessory or Piston Syringe |
|---|---|---|
| 2. | Common Name: | Medication Reservoir |
| 3. | Proprietary Name: | S.P.A.R.TM Sterile Ambulatory Reservoir |
| 4. | Classification: | Class II |
| 5. | Predicate Device: | SIMS Deltec Medication CassetteTM (K843772 |
Description of the Device: 6.
The S.P.A.R.TM Sterile Ambulatory Reservoir is a sterile, disposable, nonpyrogenic, tamper proof (evident), ambulatory, reservoir system designed for use with the SIMS Deltec CADD-PCA® Model 5800 and CADD-Prizm® Model 6100 infusion pumps.
Intended Use: 7.
The S.P.A.R.TM Ambulatory Reservoir is intended for use as an accessory to the SIMS Deltec CADD-PCA® Model 5800 and CADD-Prizm® Model 6100 infusion pumps by replacing the Deltec Medication Cassette "10 Model 2050 - 50 mL and 2100 - 100 mL with S.P.A.R.TM Sterile Ambulatory Reservoir.
The use of the S.P.A.R.T™ Ambulatory Reservoir as an accessory to the SIMS Deltec CADD-PCA® Model 5800 infusion pump was previously studied and approved for marketing by the FDA on July 18, 1997 (510(k) -K962159). The current 510(k) - 990091, covers studies and information on the SIMS Deltec CADD-Prizm® Model 6100 infusion pump.
8. Technological Characteristics:
The S.P.A.R.TM Sterile Ambulatory Reservoir uses similar technology to that found in the SIMS Deltec Medication Cassette™. In both cases, the pump platform and tubing components are in communication with the pump in the same manner.
1
9. Substantial Equivalence:
The SIMS Deltec CADD-Prizm® Model 6100 infusion pump operates when coupled with either its original SIMS Deltec reservoir, or the S.P.A.R.TM Sterile Ambulatory Reservoir. In both cases the pumping principle is the same. with flow occurring as a series of fixed volume pulses, where pulse frequency determines the nominal flow rate.
Pulse frequency is controlled electronically to a high level of accuracy. whereas, pulse volume, or stroke displacement, as it is more correctly termed, is subject to variation and is the major determinant of flow rate accuracy.
The study carried out, therefore, identified statistically significant factors affecting stroke displacement from both the original Deltec reservoir and the S.P.A.R.TM reservoir when coupled with the Deltec CADD-Prizm® Model 6100 infusion pump. The factors investigated were temperature, back pressure in the delivery line, fluid viscosity, magnitude of flow rate, and reservoir type.
10. Conclusion Based on Non-Clinical Test:
Measured stroke displacement data established the equivalence of the two reservoirs in that both are affected by the same factors in a similar manner. Reducing temperature from 40℃ to 2℃ reduces the stroke displacement in both S.P.A.R.TM and Deltec reservoirs. Changing fluid viscosity from 0.9% Sodium Chloride Injection USP to 30% Dextrose Injection, USP does not affect stroke displacement in either reservoir. Increasing back pressure from -100 mmHg to 300 mmHg reduces stroke displacement in both reservoirs. Increasing flow rate from 0.1 ml/hr to 30 mL/hr increases stroke displacement in both reservoirs. Thus, the S.P.A.R.TM reservoir can be considered substantially equivalent to the predicate device.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is a stylized image of an eagle or bird-like figure, with three curved lines representing its wings or body.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 6 1999
Dr. Heike Maaser Faulding Pharmaceutical Company 11 Commerce Drive 07016 Cranford, New Jersey
K990091 Re : S.P.A.R Sterile Ambulatory Reservoir Trade Name: Regulatory Class: II Product Code: MRZ January 8, 1999 Dated: Received: January 11, 1999
Dear Dr. Maaser:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Good Manufacturing Practice for Medical Devices: General (GMP) regulation (21 CFR Part 820) and that, through periodic GMP inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Dr. Maaser
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in yitro diagnostic devices), please contact the Office of Compliance at (301) 594-4692. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to one rogalation" (21 CFR 807.97) Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda/gov/cdrh/dsmamain.html".
Sincerely yours
Timothy A. Ulatowski
Director
Director Division of Dental, Infection Control, and General Hospital Devices Office of Device Evaluation Center for Devices and Radioloqical Health
Enclosure
4
Page 1 of 1
510(k) Number (if known):
Device Name: S.P.A.R.TM Sterile Ambulatory Reservoir
Indications For Use:
The S.P.A.R. " Sterile Ambulatory Reservoir is intended for use with the Sims Deltec CADD-PCA® Model 5800 and CADD-Prizm® Model 6100 Ambulatory Infusion Pumps, manufactured and distributed by Sims Deltec Inc., St. Paul, Minnesota. The S.P.A.R. Ambulatory Reservoir is intended for use as an accessory to the Sims Deltec CADD-PCA® Model 5800 and CADD-Prizm® Model 6100 infusion pumps by replacing the Deltec Medication Cassette ™, Model 2050 - 50 mL and 2100 - 100 mL with S.P.A.R. ™ Sterile Ambulatory Reservoir.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use_ (Per 21 CFR 801.109)
OR
Over-The-Counter-Use
Patricia Cirincionite
(Division Sign-Off)
Division of Dental, Infection Control, and General Hospital Devices
510(k) Number K990091